BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16810500)

  • 21. Activation of CREB by tauroursodeoxycholic acid protects cholangiocytes from apoptosis induced by mTOR inhibition.
    Wang L; Piguet AC; Schmidt K; Tordjmann T; Dufour JF
    Hepatology; 2005 Jun; 41(6):1241-51. PubMed ID: 15861431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xenon induces late cardiac preconditioning in vivo: a role for cyclooxygenase 2?
    Weber NC; Frässdorf J; Ratajczak C; Grueber Y; Schlack W; Hollmann MW; Preckel B
    Anesth Analg; 2008 Dec; 107(6):1807-13. PubMed ID: 19020121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
    Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protease-activated receptor-2 regulates cyclooxygenase-2 expression in human bile duct cancer via the pathways of mitogen-activated protein kinases and nuclear factor kappa B.
    Eguchi H; Iwaki K; Shibata K; Ogawa T; Ohta M; Kitano S
    J Hepatobiliary Pancreat Sci; 2011 Mar; 18(2):147-53. PubMed ID: 20740367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bile acid promotes the proliferation of squamous cell carcinoma of the esophagus, independent of its inducing COX-2 expression.
    Nishioka K; Doki Y; Miyata H; Tamura S; Yasuda T; Kimura Y; Kishi K; Yoshida K; Fujiwara Y; Yano M; Monden M
    J Surg Res; 2006 May; 132(1):130-5. PubMed ID: 16337966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lysophosphatidylcholine suppresses apoptosis and induces neurite outgrowth in PC12 cells through activation of phospholipase D2.
    Yun DH; Jeon ES; Sung SM; Ryu SH; Kim JH
    Exp Mol Med; 2006 Aug; 38(4):375-84. PubMed ID: 16953116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
    Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
    Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Partial characterization of proapoptotic action of biliary deteriorated lipids on biliary epithelial cells in pancreaticobiliary diseases.
    Fujita K; Sugiyama A; Otoshi K; Taogoshi T; Kimura Y; Kishikawa N; Kodama M; Kanno K; Kihira K; Tazuma S
    J Hepatobiliary Pancreat Sci; 2014 Mar; 21(3):212-8. PubMed ID: 23894007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis.
    Peng G; Dixon DA; Muga SJ; Smith TJ; Wargovich MJ
    Mol Carcinog; 2006 May; 45(5):309-19. PubMed ID: 16508969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inducible nitric oxide synthase upregulates cyclooxygenase-2 in mouse cholangiocytes promoting cell growth.
    Ishimura N; Bronk SF; Gores GJ
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G88-95. PubMed ID: 14977638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Lampiasi N; Foderà D; D'Alessandro N; Cusimano A; Azzolina A; Tripodo C; Florena AM; Minervini MI; Notarbartolo M; Montalto G; Cervello M
    Int J Mol Med; 2006 Feb; 17(2):245-52. PubMed ID: 16391822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical features of bile duct epithelial cells in normal and experimental liver conditions.
    Onori P; Franchitto A; Alvaro D; Gaudio E
    Ital J Anat Embryol; 2001; 106(2 Suppl 1):371-8. PubMed ID: 11729979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of lysophosphatidylcholine on expression of vascular endothelial growth factor in ECV304 cells.
    Zhang L; Rui YC; Qiu Y; Li TJ
    Acta Pharmacol Sin; 2001 Apr; 22(4):335-9. PubMed ID: 11742586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paeonol exerts an anticancer effect on human colorectal cancer cells through inhibition of PGE₂ synthesis and COX-2 expression.
    Li M; Tan SY; Wang XF
    Oncol Rep; 2014 Dec; 32(6):2845-53. PubMed ID: 25322760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bile acid-mediated induction of cyclooxygenase-2 and Mcl-1 in hepatic stellate cells.
    Kim KM; Yoon JH; Gwak GY; Kim W; Lee SH; Jang JJ; Lee HS
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1108-13. PubMed ID: 16513083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of apoptosis by Chan Su, a traditional Chinese medicine, in human bladder carcinoma T24 cells.
    Ko WS; Park TY; Park C; Kim YH; Yoon HJ; Lee SY; Hong SH; Choi BT; Lee YT; Choi YH
    Oncol Rep; 2005 Aug; 14(2):475-80. PubMed ID: 16012733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased lysophosphatidylcholine and pancreatic enzyme content in bile of patients with anomalous pancreaticobiliary ductal junction.
    Shimada K; Yanagisawa J; Nakayama F
    Hepatology; 1991 Mar; 13(3):438-44. PubMed ID: 1999314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
    Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
    Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPARγ-dependent pathway.
    Walther U; Emmrich K; Ramer R; Mittag N; Hinz B
    Oncotarget; 2016 Mar; 7(9):10345-62. PubMed ID: 26863638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between cyclooxygenase (COX)-1- and COX-2-products modulates COX-2 expression in the late phase of acute inflammation.
    Nakano M; Denda N; Matsumoto M; Kawamura M; Kawakubo Y; Hatanaka K; Hiramoto Y; Sato Y; Noshiro M; Harada Y
    Eur J Pharmacol; 2007 Mar; 559(2-3):210-8. PubMed ID: 17258197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.